An implant in which the Lobus medius (median lobe) can be treated in a simple and reliable manner. This is achieved by virtue of the fact that an implant for the treatment of a urinary tract has a wire structure. The wire structure has a loop wire, which can be expanded to form a loop, wherein at least two net wires can be stretched in this loop and the wire structure can be placed around the median lobe.

An implant and a handheld medical device using which the implant may be removed particularly easily and without traumatizing the patient. This is achieved in that a proximal end of an implant has a coupling part having a ferromagnetic element, the implant being able to be withdrawn from the urethra via this coupling part.

An implant with which a urinary tract can be treated in a simple and reliable manner is achieved in that a wire structure of an implant can be introduced into the urethra in a folded state with a distal end in the lead. The wire structure is unfolded inside the urethra for the treatment of the tissue. The ischemic pressure of the wires on the surrounding tissue results in denaturation. At least one further device for constricting or cutting into tissue is positioned on the wire structure. This at least one further device is designed in such a way that it exerts a local ischemic pressure on the median lobe in the unfolded state of the implant.

An implant for efficient and gentle treatment of the urinary tract. This is achieved in that an implant has a pressure means structure, which is constructed from at least two pressure means. These pressure means are of rod-like design and exert a local ischemic pressure on the tissue of the urethra. In addition, the pressure means are secured with their distal ends on a common distal connecting body and with their proximal ends on a common proximal connecting body, wherein the distal connecting body is secured in a fixed manner to a tightening means and the proximal connecting body is movably mounted on the tightening means.

Aspects of the present invention relate to a method for locating an expandable implant for treating BPH within the prostatic urethra of a patient. The delivery device comprises an inner tube and an outer sleeve moveable relative to the inner tube between a stored position and a deployed position. The outer sleeve surrounds the inner tube to define an annulus therebetween and the expandable implant is retained within the annulus when the outer sleeve is in the stored position.

A percutaneous urinary catheter configured to be deployed in a urinary tract, including: (a) a proximal portion; and (b) a distal portion including a retention portion configured to be deployed in a kidney and/or a renal pelvis, the retention portion including one or more drainage holes leading to one or more lumen(s) within the proximal portion, wherein the retention portion, when deployed, defines a three-dimensional shape sized and positioned to maintain patency of fluid flow between the kidney and/or renal pelvis and a proximal end of the catheter by inhibiting mucosal tissue from appreciably occluding the one or more drainage holes when negative pressure is applied through the catheter.

A percutaneous urinary catheter configured to be deployed in a urinary tract, including: (a) a proximal portion; and (b) a distal portion including a retention portion configured to be deployed in a kidney and/or a renal pelvis, the retention portion including one or more drainage holes leading to one or more lumen(s) within the proximal portion, wherein the retention portion, when deployed, defines a three-dimensional shape sized and positioned to maintain patency of fluid flow between the kidney and/or renal pelvis and a proximal end of the catheter by inhibiting mucosal tissue from appreciably occluding the one or more drainage holes when negative pressure is applied through the catheter.

Systems, instruments, methods, and compositions are described involving removing a portion of the epidermis within a donor site on a subject, and harvesting dermal plugs within the donor site. An injectable filler is formed by mincing the dermal plugs. The injectable filler is configured for injecting into a recipient site on the subject.

A medical device including an elongate member having a distal end portion, a proximal end portion, and a medial portion disposed between the distal end portion an the proximal end portion. The proximal end portion is configured to be disposed within a bladder of a patient. A portion of the proximal end portion is configured to contact an inner wall of the bladder to help retain the bladder in an expanded configuration.

A stent Includes a stent body formed by a strut. The stent body is cylindrically-shaped and extends in an axial direction. The stent body includes a plurality of helical portions and an annular portion. The strut is helically-shaped along the axial direction to form the plurality of helical portions and the strut is annularly-shaped in the circumferential direction to form the annular portion. Each of the plurality of helical portions has a distal end point and a proximal end point. The plurality of helical portions include a first helical portion and a second helical portion adjacent to the first helical portion in the axial direction. The annular portion is disposed between the first and second helical portions in the axial direction. At least one of the distal and proximal end points of the plurality of helical portions is directly connected to the annular portion.